跳至主要内容
临床试验/EUCTR2007-005882-37-IT
EUCTR2007-005882-37-IT
进行中(未招募)
不适用

RANDOMIZED CONTROLLED CLINICAL STUDY ON THE EFFICACY AND TOLERABILITY OF 0.4% HYALURONIC ACID HYPOTONIC EYE DROPS (IALUREX) VS. HYDROXYPROPYL-GUAR EYE DROPS (SYSTANE) IN THE TREATMENT OF DRY EYE SYNDROME - ND

BAUSCH&LOMB0 个研究点2008年10月24日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Dry eye syndrome
发起方
BAUSCH&LOMB
状态
进行中(未招募)
最后更新
14年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2008年10月24日
结束日期
待定
最后更新
14年前
研究类型
Interventional clinical trial of medicinal product
性别
All

研究者

发起方
BAUSCH&LOMB

入排标准

入选标准

  • Legally adult outpatients having given their written informed consent with : 1\. Dry eye syndrome (either hyposecretive or hyperevaporative type) since at least two months. 2\. Schirmer l test\&\#8804;10 mm/5 min. 3\. Positivity to vital corneal staining\&\#8805;3/15 (NEI scheme). 4\. Symptomatology of dry eye with at least two positive symptoms (VAS\>60\) in the preceding 72 hours, out of five: \-burning/stinging sensation, \-ocular discomfort while blinking \-foreign body sensation \-sensation of ocular fatigue/heaviness of the lid \-willingness to keep eyes closed. 5\. Willingness to participate in the study while following the indications
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range

排除标准

  • 1\.Age \<18 years.
  • 2\.Pregnant or lactating women.
  • 3\.Women of childbearing potential who are not using adequate contraception methods.
  • 4\.Ocular surgery within the last three months.
  • 5\.Presence or onset of eye infections or of other acute pathologies which could be resolved or modified during the course of the study independently from the treatment with study drugs.
  • 6\.Presence or onset of glaucoma.
  • 7\.Using any topical ophthalmic medication with the exception of tear substitutes and/or eye cleaning solutions for the treatment of dry eye.
  • 8\.Patients being treated with topical ocular, cyclosporine, steroidal or non steroidal, anti\-inflammatory medications within the last month.
  • 9\.Occlusion therapy with lachrymal or punctum plugs within the last 2 months.
  • 10\.Change in systemic treatment within the last 2 months.

结局指标

主要结局

未指定

相似试验